← Eichor
Study identifier: NCT04622410 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Registry for Hirschsprung Disease of the BELAPS

Condition: Hirschsprung Disease  ·  Sponsor: Universitaire Ziekenhuizen KU Leuven

PhaseN/A
Planned participants432
Who can joinAll sexes, N/A to 18 Years
Healthy volunteersNo

About this study

Registry for Hirschsprung disease of the BELAPS (Belgian Association of Pediatric Surgery) Protocol Short Title/Acronym / Sponsor name BELAPS Principal Investigator Prof. Dr. Marc Miserez Medical condition or disease under investigation Hirschsprung's disease Purpose of clinical study To register pre-, intra- and postoperative data in order to improve surgical care to paediatric patients with Hirschsprung's disease in Belgium. Primary objective The primary objective is to evaluate defecation habits at 3.5-5.5 years after surgery. Secondary objective (s) Evaluating the long-term results and evaluate risk factors for constipation / incontinence. Study Design Prospective registry Endpoints Krickenbeck score, urinary, sexual and QoL evaluation

This description comes directly from the study's public registry record.

Talk to the study team

Colette Barle  ·  colette.barle@uzleuven.be

Always discuss trial participation with your own doctor first.

Locations (1)

UZ LeuvenLeuven, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04622410